Eventide Asset Management - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 135 filers reported holding IMMUNOVANT INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q1 2023$21,558,900
-67.1%
1,390,000
-62.4%
0.40%
-69.4%
Q4 2022$65,563,530
+118.7%
3,693,720
-31.2%
1.29%
+119.2%
Q3 2022$29,979,000
+43.1%
5,372,5120.0%0.59%
+31.7%
Q2 2022$20,953,000
-29.2%
5,372,5120.0%0.45%
-3.4%
Q1 2022$29,603,000
-29.8%
5,372,512
+8.5%
0.46%
-13.9%
Q4 2021$42,174,000
-2.0%
4,950,0000.0%0.54%
-4.9%
Q3 2021$43,016,000
+20.7%
4,950,000
+46.8%
0.57%
+18.4%
Q2 2021$35,631,000
-10.2%
3,370,994
+36.3%
0.48%
-18.5%
Q1 2021$39,667,000
-7.9%
2,473,000
+165.3%
0.59%
-10.9%
Q4 2020$43,049,000
+31.3%
932,0000.0%0.66%
+2.8%
Q3 2020$32,797,000
+115.2%
932,000
+48.9%
0.64%
+94.0%
Q2 2020$15,242,000625,9500.33%
Other shareholders
IMMUNOVANT INC shareholders Q4 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 1,500,000$26,6258.85%
Deep Track Capital, LP 9,710,000$172,352,5007.24%
Logos Global Management LP 3,150,000$55,912,5006.55%
Ikarian Capital, LLC 966,700$17,158,9254.14%
COMMODORE CAPITAL LP 1,150,505$20,4213.08%
TCG Crossover Management, LLC 854,853$15,173,6412.68%
SILVERARC CAPITAL MANAGEMENT, LLC 519,614$9,223,1492.64%
COWEN AND COMPANY, LLC 1,250,000$22,187,5002.32%
BVF INC/IL 2,561,000$45,457,7501.92%
Eventide Asset Management 3,693,720$65,563,5301.29%
View complete list of IMMUNOVANT INC shareholders